Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/140149
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Survival in Living Kidney Donors: An Australian and New Zealand Cohort Study Using Data Linkage.
Author: De La Mata, N.L.
Clayton, P.A.
Kelly, P.J.
McDonald, S.
Chadban, S.
Polkinghorne, K.R.
Webster, A.C.
Citation: Transplantation Direct, 2020; 6(3):1-10
Publisher: Wolters Kluwer
Issue Date: 2020
ISSN: 2373-8731
2373-8731
Statement of
Responsibility: 
Nicole L. De La Mata, Philip A. Clayton, Patrick J. Kelly, Stephen McDonald, Steven Chadban, Kevan R. Polkinghorne, and Angela C. Webster
Abstract: Background:Living kidney donors are a highly selected healthy population expected to have high survival postdonation, but mortality studies are limited. Our study aimed to compare mortality in living kidney donors with the general population in Australia and New Zealand, hypothesizing that donor survival would exceed average survival. Methods:All living kidney donors in Australia, 2004-2013, and New Zealand, 2004-2012, from the Australian and New Zealand Living Kidney Donor Registry were included. We ascertained primary cause of death from data linkage with national death registers. Standardized mortality ratios and relative survival were estimated, matching on age, sex, calendar year, and country. Results:Among 3253 living kidney donors, there were 32 deaths over 20 331 person-years, with median follow-up 6.2 years [interquartile range: 3.9-8.4]. Only 25 donors had diabetes-fasting blood sugar level predonation, of which 3 had impaired glucose tolerance. At discharge, the median creatinine was 108 µmol/L and estimated glomerular filtration rate was 58 mL/min/1.72 m2. Four deaths occurred in the first year: 2 from immediate complications of donation, and 2 from unrelated accidental causes. The leading cause of death was cancer (n = 16). The crude mortality rate was 157 (95% confidence interval [CI], 111-222)/100 000 person-y, and the standardized mortality ratio was 0.33 (95% CI, 0.24-0.47). The 5-year cumulative relative survival was 1.019 (95% CI, 1.014-1.021), confirming that the survival probability in living kidney donors was 2% higher relative to the general population. Conclusions:As expected, mortality in living kidney donors was substantially lower than the general population and is reassuring for potential donor counseling. The Living Donor Registry only captured a third of the deaths, highlighting the benefit of data linkage to national death registries in the long-term follow-up of living kidney donors.
Keywords: Living kidney donors; mortality studies
Rights: © 2020 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
DOI: 10.1097/TXD.0000000000000975
Grant ID: NHMRC
Published version: https://journals.lww.com/
Appears in Collections:Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_140149.pdfPublished version482.98 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.